Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Commentary: estimating direct and indirect effects-fallible in theory, but in the real world?

Blakely T.

Int J Epidemiol. 2002 Feb;31(1):166-7. No abstract available.

PMID:
11914315
[PubMed - indexed for MEDLINE]
Free Article
2.

Fallibility in estimating direct effects.

Cole SR, Hernán MA.

Int J Epidemiol. 2002 Feb;31(1):163-5.

PMID:
11914314
[PubMed - indexed for MEDLINE]
Free Article
3.

Prasugrel STEMI subgroup analysis.

Shil AB, Strohm MP.

Lancet. 2009 May 30;373(9678):1846; author reply 1846-8. doi: 10.1016/S0140-6736(09)61021-7. No abstract available.

PMID:
19482212
[PubMed - indexed for MEDLINE]
4.

Warfarin, aspirin, or both after myocardial infarction.

Amit G, Ilia R, Zahger D.

N Engl J Med. 2003 Jan 16;348(3):256-7; author reply 256-7. No abstract available.

PMID:
12530435
[PubMed - indexed for MEDLINE]
5.

Warfarin, aspirin, or both after myocardial infarction.

Aronow WS.

N Engl J Med. 2003 Jan 16;348(3):256-7; author reply 256-7. No abstract available.

PMID:
12530434
[PubMed - indexed for MEDLINE]
6.

Enhancing reperfusion therapy for myocardial infarction with dual antiplatelet therapy: Breaking the glass ceiling.

Fathi RB, Bhatt DL.

Am Heart J. 2005 Jun;149(6):947-9. No abstract available.

PMID:
15976770
[PubMed - indexed for MEDLINE]
7.

Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.

Rothberg M.

Ann Intern Med. 2005 Sep 20;143(6):464; author reply 464-5. No abstract available.

PMID:
16172448
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.

Eriksson P.

Ann Intern Med. 2005 Sep 20;143(6):464; author reply 464-5. No abstract available.

PMID:
16172447
[PubMed - indexed for MEDLINE]
9.

Aspirin in the primary prevention of vascular disease.

Cleland JG.

Lancet. 2009 Sep 12;374(9693):878; author reply 879. doi: 10.1016/S0140-6736(09)61622-6. No abstract available.

PMID:
19748392
[PubMed - indexed for MEDLINE]
10.

[Aspirin for primary prevention of cardiovascular diseases].

Li XY.

Zhonghua Yi Xue Za Zhi. 2005 Apr 6;85(13):889-91. Chinese. No abstract available.

PMID:
16029526
[PubMed - indexed for MEDLINE]
11.

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ.

Am J Cardiol. 2002 Sep 15;90(6):625-8. No abstract available.

PMID:
12231089
[PubMed - indexed for MEDLINE]
12.

Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.

[No authors listed]

Prescrire Int. 2007 Aug;16(90):146.

PMID:
17724837
[PubMed - indexed for MEDLINE]
13.

[Antiplatelet agents--problem for cardiac surgeon].

Bochenek A, Wilczyński M.

Kardiol Pol. 2006 Nov;64(11):1329-31. Review. Polish. No abstract available.

PMID:
17165174
[PubMed - indexed for MEDLINE]
Free Article
14.

Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction.

Darbà J, Izquierdo I, Pontes C, Navas C, Rovira J.

Pharmacoeconomics. 2002;20(3):195-201.

PMID:
11929349
[PubMed - indexed for MEDLINE]
15.

The (variable) definition of benefit in the case of clopidogrel vs aspirin.

Hansen DB.

Arch Intern Med. 2005 Jun 13;165(11):1310; author reply 1310-1. No abstract available.

PMID:
15956013
[PubMed - indexed for MEDLINE]
16.

Clopidogrel and metoprolol in myocardial infarction.

Borja J, García O, Donado E, Izquierdo I.

Lancet. 2006 Mar 11;367(9513):811-2. No abstract available.

PMID:
16530566
[PubMed - indexed for MEDLINE]
17.

Aspirin and its rivals. As your options increase, your choices get harder.

[No authors listed]

Harv Mens Health Watch. 2002 Dec;7(5):1-5. Review. No abstract available.

PMID:
12499131
[PubMed - indexed for MEDLINE]
18.

The role of platelets and platelet inhibition in acute myocardial infarction.

Valettas N, Herrmann HC.

Coron Artery Dis. 2003 Aug;14(5):357-63. Review. No abstract available.

PMID:
12878900
[PubMed - indexed for MEDLINE]
19.

Summaries for patients. Is it cost-effective to treat high-risk cardiac patients with clopidogrel plus aspirin as opposed to aspirin alone?

[No authors listed]

Ann Intern Med. 2005 Feb 15;142(4):I53. No abstract available.

PMID:
15710954
[PubMed - indexed for MEDLINE]
20.

Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study.

Dalby M, Montalescot G, Bal dit Sollier C, Vicaut E, Soulat T, Collet JP, Choussat R, Gallois V, Drobinski G, Drouet L, Thomas D.

J Am Coll Cardiol. 2004 Jan 21;43(2):162-8.

PMID:
14736431
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk